Q1 2023

Filed May 15, 2023 · 10-Q · 45 days after period end · 0001493152-23-016948

Q1 2023 · 10-Q

Revenue

$30.00K

no prior Q1 2022 on file

Net Income

$1.22K

N/M vs Q1 2022

EPS, diluted—

Operating Income$1,225N/M

Operating Cash Flow$18,219N/M

Same quarter

Metric	Q1 2023	Q1 2022	Q1 2021	Q1 2020
Revenue	$30.00K	—	—	$15.00K
Net Income	$1.22K	-$31.09K	-$24.24K	-$30.12K
EPS Diluted	—	—	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR